Results 101 to 110 of about 206,766 (202)

Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems. [PDF]

J Pediatr Health Care
Zauche LH, Miller ER, Kim SS, Jazwa A, Shay DK.   +4 more
europepmc   +1 more source

Editorial: Pandemic preparedness in vaccine safety and regulation. [PDF]

Front Drug Saf Regul
Younus MM, van Hunsel F.
europepmc   +1 more source

Safety of pentavalent vaccines [PDF]

Indian Pediatrics, 2013
openaire   +2 more sources

Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination

Signal Transduction and Targeted Therapy, 2022
Weijun Zhao, Huajun Zhao, Baoying Huang, Tongyi Zhao, Limei Wang, Jian Zhang, Yong Yang, Xinying Tang, Wenjie Tan, Ang Lin   +9 more
doaj   +1 more source

Development and psychometric testing of a parental knowledge, attitude, and practices questionnaire on pentavalent vaccine safety. [PDF]

Indian J Med Res
Fathima F, Nosenoor MM.
europepmc   +1 more source

A Post-Authorisation Safety Study of a Respiratory Syncytial Virus Vaccine in Pregnant Women and Their Offspring in a Real-World Setting: Generic Protocol for a Target Trial Emulation

Background: Assessing the real-world safety of preventive products against respiratory syncytial virus (RSV) in pregnant women holds significant public health implications, especially as vaccination programs become more widespread.
Kitty Bloemenkamp, Miriam Sturkenboom, Heather Rubino, Fariba Ahmadizar, Oisin Ryan, Hae-Won Uh, Linda Nab, Odette de Bruin, Shahar Shmuel, Jungyeon Choi, Cynthia de Luise   +10 more
core   +1 more source

Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021-23. [PDF]

Hum Vaccin Immunother
Belongia EA, Kieke BA, Hanson KE, McClure DL, Boyce TG, Daley MF, DeSilva MB, Hurley LP, Irving SA, Jackson LA, Duffy J, McNeil MM, Sundaram ME.   +12 more
europepmc   +1 more source

Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2

Viral vector vaccines represent a substantial advancement in immunization technology, offering numerous benefits over traditional vaccine modalities. The Orf virus (ORFV) strain D1701-VrV is a particularly promising candidate for vaccine development due ...
Verena Haug, Carina Metz, Melanie Müller, Ralf Amann   +3 more
core   +1 more source

Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network. [PDF]

Hum Vaccin Immunother
Viñeta Paramo M, Kiely M, Valiquette L, Muller MP, McGeer A, Isenor JE, Sadarangani M, Kellner JD, Vanderkooi OG, Marty K, Lavoie PM, Bettinger JA.   +11 more
europepmc   +1 more source

Four immediate steps when responding to an event that may erode trust: World Health Organization vaccine safety supporting document

, 2017
2 p.Vaccine-safety-related events, and how we respond to them, can affect public trust in vaccines and health authorities. These events may or may not be linked to vaccines and include: adverse events following immunization (AEFIs), vaccination programme
World Health Organization. Regional Office for Europe
core   +1 more source